UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

Cancer chemotherapy and pharmacology, 2019-01, Vol.83 (1), p.131-143

2019

Volltextzugriff (PDF)

Are male gender and non-adenocarcinoma histology valid prognostic factors for breast cancer?

Annals of oncology, 2014-04, Vol.25 (4), p.911-911

2014

Volltextzugriff (PDF)

Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?

Annals of oncology, 2006-02, Vol.17 (2), p.349-350

2006

Volltextzugriff (PDF)

Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Annals of oncology, 2018-10, Vol.29, p.viii104-viii105

2018

Volltextzugriff (PDF)

Abstract P5-02-03: Testing machine learning algorithms' performance for non-invasively identifying breast cancer molecular subtypes using BI-RADS evaluations

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-02-03

2019

Volltextzugriff (PDF)

Change of PD-L1 expression status of high grade glial tumors at recurrence and its effect on survival

Annals of oncology, 2017-09, Vol.28, p.v111-v112

2017

Volltextzugriff (PDF)

EE193 The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey

Value in health, 2022-07, Vol.25 (7), p.S371

2022

Volltextzugriff (PDF)

The acute effect of trastuzumab infusion on ECG parameters in metastatic breast cancer patients

Swiss medical weekly, 2007-10

2007

Volltextzugriff (PDF)

The acute effects of palonosetron on ECG parameters in patients with cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e19693-e19693

2011

Volltextzugriff (PDF)

P2.17-23 The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S892-S893

2019

Volltextzugriff (PDF)

Adding a single high-dose chemotherapy cycle to three cycles of standard salvage chemotherapy for relapsed germ-cell tumours does not improve clinical outcomes

Cancer treatment reviews, 2006-02, Vol.32 (1), p.45-49

Oyan, Basak

2006

Volltextzugriff (PDF)

The prognostic relevance of response evaluation to chemotherapy by FDG-PET/CT in patients with metastatic non-small cell lung cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18055-e18055

2011

Volltextzugriff (PDF)

The early metabolic effect of zolendronic acid on FDG-PET scans in patients with bone metastasis

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21168-e21168

2011

Volltextzugriff (PDF)

Abstract P5-02-05: Correlation of proliferation index markers (Ki-76 and PHH3) with breast MRI apparent diffusion coefficient values

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-02-05

2019

Volltextzugriff (PDF)

Reply to the letter to the editor 'Are male gender and nonadenocarcinoma histology valid prognostic factors for breast cancer?' by Eren et al

Annals of oncology, 2014-04, Vol.25 (4), p.911

2014

Volltextzugriff (PDF)

Are male gender and non-adenocarcinoma histology valid prognostic factors for breast cancer?

Annals of oncology, 2014-04, Vol.25 (4), p.911

2014

Volltextzugriff (PDF)

124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey

Annals of oncology, 2021-05, Vol.32, p.S74

2021

Volltextzugriff (PDF)

Prevalence and correlates of metabolic syndrome (MS) in older adults

Archives of gerontology and geriatrics, 2006, Vol.42 (1), p.35-45

2006

Volltextzugriff (PDF)

325PPertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Alprazolam Significantly Improves the Efficacy of Granisetron in the Prophylaxis of Emesis Secondary to Moderately Emetogenic Chemotherapy in Patients with Breast Cancer

Chemotherapy (Basel), 2005-08, Vol.51 (5), p.280-285

2005

Volltextzugriff (PDF)

Improvement of chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal photopheresis

Medical oncology (Northwood, London, England), 2006, Vol.23 (1), p.125-130

2006

Volltextzugriff (PDF)

P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S477-S478

2018

Volltextzugriff (PDF)

Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8081-8081

2004

Volltextzugriff (PDF)

Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8081-8081

2004

Volltextzugriff (PDF)

Successful salvage with high-dose sequential chemotherapy coupled with in vivo purging and autologous stem cell transplantation in 2 patients with primary refractory mantle cell lymphoma presenting in the leukemic phase

International journal of hematology, 2005-02, Vol.81 (2), p.155-158

2005

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(101)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

Are male gender and non-adenocarcinoma histology valid prognostic factors for breast cancer?

Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?

Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Abstract P5-02-03: Testing machine learning algorithms' performance for non-invasively identifying breast cancer molecular subtypes using BI-RADS evaluations

Change of PD-L1 expression status of high grade glial tumors at recurrence and its effect on survival

EE193 The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey

The acute effect of trastuzumab infusion on ECG parameters in metastatic breast cancer patients

The acute effects of palonosetron on ECG parameters in patients with cancer

P2.17-23 The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study

Adding a single high-dose chemotherapy cycle to three cycles of standard salvage chemotherapy for relapsed germ-cell tumours does not improve clinical outcomes

The prognostic relevance of response evaluation to chemotherapy by FDG-PET/CT in patients with metastatic non-small cell lung cancer

The early metabolic effect of zolendronic acid on FDG-PET scans in patients with bone metastasis

Abstract P5-02-05: Correlation of proliferation index markers (Ki-76 and PHH3) with breast MRI apparent diffusion coefficient values

Reply to the letter to the editor 'Are male gender and nonadenocarcinoma histology valid prognostic factors for breast cancer?' by Eren et al

Are male gender and non-adenocarcinoma histology valid prognostic factors for breast cancer?

124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey

Prevalence and correlates of metabolic syndrome (MS) in older adults

325PPertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Alprazolam Significantly Improves the Efficacy of Granisetron in the Prophylaxis of Emesis Secondary to Moderately Emetogenic Chemotherapy in Patients with Breast Cancer

Improvement of chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal photopheresis

P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial

Granisetron plus alprazolam versus granisetron alone in the control of emesis in patients with operable breast cancer receiving anthracycline containing chemotherapy: A phase III trial

Successful salvage with high-dose sequential chemotherapy coupled with in vivo purging and autologous stem cell transplantation in 2 patients with primary refractory mantle cell lymphoma presenting in the leukemic phase

Suchergebnisse filtern